Almirall, S.a.

This study tested a medicated ointment called tirbanibulin on adults with actinic keratosis, rough patches caused by sun damage. The goal was to see if it works safely on larger skin areas (up to 100 cm²) on the face or scalp. About 280 participants applied the ointment or a plac…

This observational study followed 331 adults with moderate to severe plaque psoriasis who were treated with tildrakizumab (Ilumetri) in routine medical practice. Researchers measured how much the skin cleared up and how quality of life improved over 48 to 100 weeks. The goal was …

This study looked at the long-term safety and effectiveness of lebrikizumab for adults and teens with moderate-to-severe atopic dermatitis (eczema). Participants who had already completed a previous study were given lebrikizumab for up to 2 more years. The goal was to see how man…

This study involved 291 adults with mild-to-moderate scalp psoriasis who used a prescription cream (CAL/BDP PAD cream). Researchers measured how satisfied patients were with the treatment, its effect on their quality of life, and how well it worked in real-world settings. The goa…

This early-stage study tested the safety and tolerability of a new drug called LAD603 in 92 healthy adults aged 18 to 65. Participants received either the drug or a placebo to check for side effects and how the drug moves through the body. The goal was not to treat any disease, b…

This early-stage study tested the safety of a new drug called LAD191 in 69 adults—some healthy and some with an autoimmune disease. Researchers measured side effects, how the drug moves through the body, and whether it triggers an immune response. The goal was not to treat the di…